Hemophilia B, also called the Christmas disease, is a blood coagulation disorder due to the deficiency or improper function of factor IX. It is inherited in an X-linked recessive pattern. This disorder is more prevalent in males than in females. Factor replacement therapies, mainly recombinant, are used in the treatment. The analysts forecast the global hemophilia B market to grow posting a CAGR of 4.18% over the period 2014-2019. Covered in this report The report includes the present scenario and the growth prospects of the global hemophilia B market for ...more >>
from Infiniti Research Limited Market Research Reports http://ift.tt/1hgZObT
via IFTTT
